A passionate physician, clinical researcher, educator and leader, Dr. Missak Haigentz is chief of Hematology and Oncology at Morristown Medical Center and medical director of Atlantic Hematology and Oncology for Atlantic Medical Group at the Carol G. Simon Cancer Center.
Dr. Haigentz is recognized nationally and internationally as an expert in cancers of the head and neck, including thyroid cancers, and in lung cancers. As past director of the clinical trials office of the National Cancer Institute-designated Albert Einstein Cancer Center, Dr. Haigentz has particular expertise in the design and conduct of innovative clinical trials to improve the lives of cancer patients, and he has led several multicenter and national clinical trials. His research has received funding from the National Institutes of Health and the Conquer Cancer Foundation of the American Society of Clinical Oncology.
He is the author of numerous peer-reviewed manuscripts, review articles, and book chapters, and he has served on the editorial board of the Journal of Clinical Oncology. Dr. Haigentz has held several leadership roles, including service as president of the New York Head and Neck Society (2014-2015). Throughout his career, Dr. Haigentz has taken pride in providing compassionate and personalized cancer care.
Dr. Haigentz earned his undergraduate degree at the University of California, Los Angeles, and his medical degree from the New Jersey Medical School in 1995. After completing residency training in internal medicine at New Jersey Medical School in 1998 (where he also served as chief medical resident), he received subspecialty fellowship training in hematology and oncology at the New York University School of Medicine. In 2001, Dr. Haigentz was recruited to the faculty of the Albert Einstein College of Medicine, where he rose to the rank of professor of medicine (oncology) and otorhinolaryngology - head and neck surgery.